Xilio Therapeutics (XLO) Debt Ratio (2020 - 2023)

Xilio Therapeutics has disclosed Debt Ratio across 4 years of filings, most recently posting 0.01 for Q1 2023.

• Debt Ratio for Q1 2023 came in at 0.01, down 65.98% year-over-year; the trailing twelve-month figure through Mar 2023 was 0.01 (down 65.98% YoY), and the FY2022 annual result was 0.02, down 48.49% from the prior year.
• Debt Ratio came in at 0.01 for Q1 2023 at Xilio Therapeutics, down from 0.02 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.2 in Q4 2020 to a low of 0.01 in Q1 2023.
• The 4-year median for Debt Ratio is 0.04 (2022), against an average of 0.06.
• Across the five-year window, Debt Ratio plunged 78.37% in 2021 and slumped 48.49% in 2022, its largest moves.
• Xilio Therapeutics' Debt Ratio stood at 0.2 in 2020, then slumped by 78.37% to 0.04 in 2021, then plunged by 48.49% to 0.02 in 2022, then slumped by 38.96% to 0.01 in 2023.
• The last three Debt Ratio figures came in at 0.01 (Q1 2023), 0.02 (Q4 2022), and 0.03 (Q3 2022), per Business Quant data.